New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Peptides for Weight Loss: What to Know, According to Experts.
- New NJACTS Publication
- Nine Dimensions of Authentic Community Engagement
- Rutgers study finds patients with schizophrenia are less likely to be rehospitalized when given antipsychotic injections.
- Taking Proactive Steps, Rutgers Provides Free Narcan to the Community.